Blaise A. Aguirre net worth and biography

Blaise Aguirre Biography and Net Worth

Director of United States Antimony

Blaise A. Aguirre, MD: Dr. Aguirre joined the Board of Directors of United States Antimony Corp. on August 14 2019, to replace a Director that retired for medical reasons. He received his Medical Doctor’s degree in 1989 from the University of the Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994. He is an Assistant Professor of Psychiatry at Harvard Medical School and he is the founding Medical Director of 3East at McLean Hospital. Blaise is fluent in Spanish and lectures worldwide. He was elected to the Board at Investors Capital Holdings, Ltd in 2011 and remained on the Board until it was sold to RCAP. He sits on the boards of various privately held companies. He developed and maintains enduring relationships with institutional money managers, venture capitalists, Angel investors and developed an expertise as a small cap stock analyst as a broker with series 7 and 63 securities licenses.

What is Blaise A. Aguirre's net worth?: The estimated net worth of Blaise A. Aguirre is at least $4.10 million as of August 31st, 2026. Dr. Aguirre owns 878,092 shares of United States Antimony stock worth more than $4,100,690 as of September 2nd. This net worth estimate does not reflect any other assets that Dr. Aguirre may own. Learn More about Blaise A. Aguirre's net worth.
How do I contact Blaise A. Aguirre?: The corporate mailing address for Dr. Aguirre and other United States Antimony executives is P O BOX 643, THOMPSON FALLS MT, 59873. United States Antimony can also be reached via phone at (406) 827-3523 and via email at [email protected]. Learn More on Blaise A. Aguirre's contact information.
Has Blaise A. Aguirre been buying or selling shares of United States Antimony?: In the last ninety days, Blaise A. Aguirre has bought $7,056.00 in shares of United States Antimony stock. Most recently, on Monday, August 31st, Blaise A. Aguirre bought 1,400 shares of United States Antimony stock. The stock was acquired at an average cost of $5.04 per share, with a total value of $7,056.00. Following the completion of the transaction, the director now directly owns 878,092 shares of the company's stock, valued at $4,425,583.68. Learn More on Blaise A. Aguirre's trading history.
Who are United States Antimony's active insiders?: United States Antimony's insider roster includes Blaise Aguirre (Director), Gary Evans (CEO), Richard Isaak ( Senior Vice President & Chief Financial Officer), Jon Marinelli (Director), and Michael McManus, Jr. (Director). Learn More on United States Antimony's active insiders.
Are insiders buying or selling shares of United States Antimony?: In the last year, United States Antimony insiders bought shares 5 times. They purchased a total of 155,200 shares worth more than $912,117.00. The most recent insider tranaction occured on September, 1st when Director Joseph A Carrabba bought 21,300 shares worth more than $100,536.00. Insiders at United States Antimony own 5.5% of the company. Learn More about insider trades at United States Antimony.
Information on this page was last updated on 9/1/2026.

Blaise A. Aguirre Insider Trading History at United States Antimony

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/31/2026	Buy	1,400	$5.04	$7,056.00	878,092

Blaise A. Aguirre Buying and Selling Activity at United States Antimony

United States Antimony Company Overview

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance. The company also offers coarse and fine zeolite for soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, and animal nutrition applications, as well as in catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, and floor cleaners, as well as carriers for insecticides, pesticides, and herbicides. In addition, it recovers unrefined and refined gold and silver. United States Antimony Corporation was founded in 1968 and is based in Thompson Falls, Montana.

Today's Range

Now: $4.96

$4.74

50 Day Range

MA: $5.92

$4.67

$7.72

2 Week Range

Now: $4.96

$4.25

$19.71

Volume

95,854 shs

Average Volume

11,187,271 shs

Market Capitalization

$741.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39